Hepatitis C
HIVandHepatitis.com 2017 Conference Coverage
- Details
- Category: HIV Treatment
- Published on Saturday, 30 December 2017 00:00
Article listings by topic for HIVandHepatitis.com conference coverage in 2017, including the Conference on Retroviruses and Opportunistic Infections, EASL International Liver Congress, IAS Conference on HIV Science, and AASLD Liver Meeting.
AASLD 2017: Nivolumab Improves Outcomes in Liver Cancer Study
- Details
- Category: Liver Cancer/HCC
- Published on Thursday, 30 November 2017 00:00
Nivolumab (Opdivo), a PD-1 checkpoint inhibitor that helps the immune system fight cancer, was associated with a decrease in tumor size or disease stabilization in patients with hepatocellular carcinoma (HCC) in the CheckMate 040 study, according to a report at the 2017 AASLD Liver Meeting last month in Washington, DC.
Coverage of the 2017 AASLD Liver Meeting
- Details
- Category: Hepatitis B
- Published on Thursday, 30 November 2017 00:00
HIVandHepatitis.com coverage of the 2017 Liver Meeting, the annual conference of the American Association for the Study of Liver Diseases, AASLD), October 20-24, 2017, in Washington, DC.
AASLD 2017: More Work and Lower Drug Prices Needed to Eliminate Hepatitis C Worldwide
- Details
- Category: HCV Treatment
- Published on Thursday, 30 November 2017 00:00
Eliminating hepatitis C virus (HCV) as a global public health concern is feasible, but to do so more people need to be tested and treated, and prices of direct-acting antivirals need to come down, according to presentations at the AASLD Liver Meeting last month in Washington, DC.
AASLD 2017: Model Shows Hepatitis C Treatment is Cost-Effective in Japan
- Details
- Category: HCV Treatment
- Published on Tuesday, 28 November 2017 00:00
Treatment of chronic hepatitis C with direct-acting antivirals can lead to substantial savings by preventing the development of liver failure and liver cancer, according to a mathematical modeling study presented at the AASLD Liver Meeting in October in Washington, DC.
AASLD 2017: Sofosbuvir/Ledipasvir for 8 Weeks Cures Acute HCV in People with HIV
- Details
- Category: HCV Treatment
- Published on Thursday, 30 November 2017 00:00
An 8-week course of sofosbuvir/ledipasvir (Harvoni) led to sustained response in all HIV-positive with genotype 1 or 4 acute hepatitis C virus (HCV) infection in the SWIFT-C study, according to a reportat the AASLD Liver Meeting last month in Washington, DC.
AASLD 2017: Hepatitis C Testing Linked to Reduced Opioid Use
- Details
- Category: Injection Drug Use
- Published on Sunday, 26 November 2017 00:00
Getting tested for hepatitis C virus (HCV) was associated with reduced drug use, especially among those who tested positive, but evenpeople who tested negative saw some reduction, according to study results presented at the AASLD Liver Meeting in October in Washington, DC.
AASLD 2017: Sofosbuvir/Ledipasvir for 8 Weeks Cures Acute HCV in People with HIV
- Details
- Category: HCV Treatment
- Published on Thursday, 30 November 2017 00:00
An 8-week course of sofosbuvir/ledipasvir (Harvoni) led to sustained response in all HIV-positive with genotype 1 or 4 acute hepatitis C virus (HCV) infection in the SWIFT-C study, according to a reportat the AASLD Liver Meeting last month in Washington, DC.
AASLD 2017: Curing Hepatitis C Leads to Improved Quality of Life
- Details
- Category: HCV Treatment
- Published on Tuesday, 31 October 2017 00:00
People who were cured of hepatitis C with direct-acting antivirals had sustained improvements in their health-related quality of life, including both physical and mental health measures, according to study results presented at the AASLD Liver Meeting last week in Washington, DC.
More Articles...
- AASLD 2017: Mavyret Shows High Cure Rates for HCV Genotype 3 and Cirrhosis
- AASLD 2017: Curing Hepatitis C with DAAs Reduces Liver Cancer Risk
- AASLD 2017: HCV Infections Are Rising Among HIV+ Gay Men In San Diego
- EACS 2017: Test-and-Treat Reduces HCV Among Gay Men in Swiss HIV Cohort
- EACS 2017: High Rate of Hepatitis C Reinfection in German Men Who Have Sex With Men
Web Design and Development by